Biocon Biologics 2022 Press Meet

Biocon Biologics presented its global vertically integrated biosimilars platform at a press meeting in February 2022. The company reported USD 384 million in annual revenue and highlighted its mission to expand equitable access to high-quality biologics through global partnerships and advanced manufacturing capabilities, serving over 3.6 million patients.